Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 53.00
-0.82 (-1.52%)
At close: Feb 6, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 24.63 billion as of February 6, 2026. Its market cap has increased by 51.57% in one year.
Market Cap
24.63B
Enterprise Value
23.76B
Revenue
607.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.00
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 24.63B, an increase of 49.79%. That is a compound annual growth rate of 10.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 24.63B | -7.30% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 28.95B |
| Chengdu Kanghong Pharmaceutical Group | 26.72B |
| Kangmei Pharmaceutical | 26.27B |
| Hubei Jumpcan Pharmaceutical | 24.66B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 23.81B |
| Zhejiang Huahai Pharmaceutical | 23.49B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 22.81B |
| Tasly Pharmaceutical Group | 22.44B |